Ryan M. Dunlap
Independent DirectorMr. Ryan M. Dunlap, CPA, has been an Independent Director at CytoDyn Inc. since August 24, 2022. He serves as the Chief Financial Officer and Head of Corporate Strategy of Galena Biopharma, Inc. and was Vice President. He was CFO since January 2016, as well as COO since December 2017, at MolecularMD (now ICON Specialty Labs). Mr. Dunlap served as a Chief Financial Officer at Gurobi Optimization, LLC until May 2026. Prior to joining Gurobi in October?2019, he spent several years as the CFO and COO for a growth equity-backed molecular diagnostics company. Prior to that he served for four years as the CFO of a publicly traded biotechnology and pharmaceutical sales company. Mr. Dunlap served as the Principal Accounting Officer at Galena Biopharma, Inc. since July 16, 2012. He served as Director of Finance at Galena Biopharma, Inc. since July 16, 2012. He served as Corporate Secretary of Galena Biopharma, Inc. until July 2014 and also served as its Controller since July 16, 2012. He has vast experience in finance and operations leadership at both public and private companies, developing significant expertise in strategy setting, improving operational efficiency and effectiveness, fundraising and investor relations, financial reporting and compliance and risk management. Earlier in his career, Mr. Dunlap held various financial and operational leadership roles in large, multinational organizations and spent 11 years with various public accounting firms, including PricewaterhouseCoopers LLP, KPMG LLP and Moss Adams LLP, where he provided business assurance and advisory services to both public and private companies, including companies in the life sciences industry. He served as Senior Manager, Business Assurance of Moss Adams, LLP from June 2008 to June 2012, where he provided assurance and consulting services with a focus on technology and life sciences. From 2007 to 2008, he served as Director of Financial Accounting at Vestas American Wind Technology, Inc. a private company that engages in the sale and service of wind turbines in North America and is a subsidiary of Vestas Wind Systems A/S, a public company that engages in the manufacture and sale of wind turbines and wind power systems globally. From 2005 to 2007, Mr. Dunlap served as Senior Manager, Business Assurance of KPMG, LLP, where he provided external audit and business advisory services to emerging and established public and private and international and domestic entities. Mr. Dunlap has also been the Project Lead, Corporate Audit from 2002 to 2005 of Nike, Inc. where he planned and executed several operational and financial internal audits of various regions and business units. He served as a Director at Galena Biopharma, Inc. since July 16, 2012. Mr. Dunlap is a certified public accountant and holds a BS degree in accounting from the University of Oregon.
Positions
- Company NameCytoDyn Inc.Stock CodeCYDYPositionIndependent DirectorColleagues
- RERobert E. HoffmanCEO & Principal Accounting Officer
- TDTanya Durkee UrbachIndependent Chairman of the Board
- TBTyler BlokChief Legal Officer & Corporate Secretary
- JPJacob P. LalezariHead of Research and Translational Sciences
- LWLauren WilcoxenCOO & Head of Regulatory Affairs
- SMStephen M. SimesIndependent Director
- JBJonah B. SachaMember of Scientific Advisory Board
- HSHope S. RugoMember of Scientific Advisory Board
